Sildenafil citrate: A novel therapy for intrauterine growth restriction

Summary

Sildenafil citrate: A novel therapy for intrauterine growth restriction is a doctoral thesis^[1].

Key Facts

• Sildenafil citrate: A novel therapy for intrauterine growth restriction authored A novel therapy for intrauterine growth restriction — author (P50): Charlotte Oyston^[2].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's instance of is recorded as A novel therapy for intrauterine growth restriction — instance of (P31): doctoral thesis^[3].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's publisher is recorded as A novel therapy for intrauterine growth restriction — publisher (P123): ResearchSpace@Auckland^[4].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's country of origin is recorded as A novel therapy for intrauterine growth restriction — country of origin (P495): New Zealand^[5].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's publication date is recorded as +2016-00-00T00:00:00Z^[6].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's main subject is recorded as A novel therapy for intrauterine growth restriction — main subject (P921): obstetrics and gynaecology^[7].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/36841^[8].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's Handle ID is recorded as 2292/36841^[9].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's title is recorded as Sildenafil citrate: A novel therapy for intrauterine growth restriction^[10].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's copyright holder is recorded as A novel therapy for intrauterine growth restriction — copyright holder (P3931): Charlotte Oyston^[11].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's thesis submitted to is recorded as A novel therapy for intrauterine growth restriction — thesis submitted to (P4101): University of Auckland^[12].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's on focus list of Wikimedia project is recorded as A novel therapy for intrauterine growth restriction — on focus list of Wikimedia project (P5008): NZThesisProject^[13].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's copyright status is recorded as A novel therapy for intrauterine growth restriction — copyright status (P6216): copyrighted^[14].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's online access status is recorded as A novel therapy for intrauterine growth restriction — online access status (P6954): open access^[15].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's thesis committee member is recorded as A novel therapy for intrauterine growth restriction — thesis committee member (P9161): Philip Baker^[16].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's thesis committee member is recorded as A novel therapy for intrauterine growth restriction — thesis committee member (P9161): Joanna Stanley^[17].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's thesis committee member is recorded as A novel therapy for intrauterine growth restriction — thesis committee member (P9161): Frank Bloomfield^[18].
• Sildenafil citrate: A novel therapy for intrauterine growth restriction's thesis committee member is recorded as A novel therapy for intrauterine growth restriction — thesis committee member (P9161): Katie Groom^[19].

Body

Designation and Status

Sildenafil citrate: A novel therapy for intrauterine growth restriction's instance of is recorded as A novel therapy for intrauterine growth restriction — instance of (P31): doctoral thesis^[3].